Pages that link to "Q38259952"
Jump to navigation
Jump to search
The following pages link to Adverse effects of statins - myths and reality (Q38259952):
Displaying 19 items.
- PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab (Q26747776) (← links)
- Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway (Q26771260) (← links)
- Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study (Q37612171) (← links)
- The Effects of Tocotrienol and Lovastatin Co-Supplementation on Bone Dynamic Histomorphometry and Bone Morphogenetic Protein-2 Expression in Rats with Estrogen Deficiency. (Q37673232) (← links)
- Management of patients with familial hypercholesterolaemia (Q38528246) (← links)
- Do statin users adhere to a healthy diet and lifestyle? The Australian Diabetes, Obesity and Lifestyle Study. (Q38888073) (← links)
- Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms (Q39052351) (← links)
- Hypertriglyceridaemia and risk of coronary artery disease (Q39181612) (← links)
- One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial. (Q40769656) (← links)
- Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel (Q41549715) (← links)
- PCSK9 inhibitors--past, present and future (Q42643131) (← links)
- Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience. (Q48176908) (← links)
- Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice (Q51479885) (← links)
- Effectiveness and safety of combinational therapy compared with intensified statin monotherapy in patients with coronary heart disease. (Q55240562) (← links)
- Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy (Q58550770) (← links)
- Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors (Q60045844) (← links)
- Comparative efficacy and safety of lipid-lowering agents in patients with hypercholesterolemia: A frequentist network meta-analysis (Q64256576) (← links)
- Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness (Q64298937) (← links)
- Association between Statin Use and Sepsis Risk in Patients with Dementia: A Retrospective Cohort Study. (Q64972144) (← links)